Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132042) titled 'AMachineLearning-BasedSerologicalPrediction Model for Liver Fibrosis Severity in Metabolic Dysfunction-Associated Steatotic Liver Disease: FibroScan as the Reference Standard' on Sept. 9.
Study Type: Observational study
Study Design:
Cross-sectional
Primary Sponsor: The affiliated hospital of southwest medical university
Condition:
Metabolic-associated fatty liver disease
Intervention:
Internal validation set:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-09-10
Target Sample Size: Internal validation set:450;Training set:1050;
Countries of Recruitment:
China
To...